Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients

NCT06353828 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: CBD, synthetic form
DRUG: Placebo

Sponsor

CannaMore Biotechs